| Alopecia |
1 |
1 |
| Alopecia Areata |
0 |
0.99 |
| Hair |
0 |
0.6 |
| Skin and Soft Tissue Infection |
0 |
0.47 |
| Acne |
0 |
0.26 |
| Food and Drug Administration (FDA) |
0 |
0.98 |
| Otolaryngology |
0 |
0.2 |
| Blood |
0 |
0.17 |
| Washington |
0 |
0.17 |
| Thrombus |
0 |
0.15 |
| Scalp |
0 |
0.13 |
| Adverse Effects |
0 |
0.09 |
| Allergy |
0 |
0.09 |
| Aminotransferase |
0 |
0.09 |
| Clinical Research |
0 |
0.09 |
| Liver |
0 |
0.09 |
| Liver Disease |
0 |
0.09 |
| Pain Management |
0 |
0.08 |
| Abdominal Pain |
0 |
0.07 |
| Biologic Therapy |
0 |
0.07 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Herpes Zoster |
0 |
0.07 |
| Patient Safety |
0 |
0.07 |
| Thromboembolism |
0 |
0.07 |
| Lower Respiratory Tract Infection |
0 |
0.06 |
| Rheumatoid Arthritis |
0 |
0.05 |
| Abdomen |
0 |
0.04 |
| Anemia |
0 |
0.04 |
| Arthritis |
0 |
0.04 |
| Autoimmune Disease |
0 |
0.04 |
| Board Certification |
0 |
0.04 |
| California |
0 |
0.04 |
| Chronic Disease |
0 |
0.04 |
| Ear |
0 |
0.04 |
| Fatigue |
0 |
0.04 |
| Folliculitis |
0 |
0.04 |
| Insurance |
0 |
0.04 |
| Metabolism |
0 |
0.04 |
| Nausea |
0 |
0.04 |
| Neutrophils |
0 |
0.04 |
| New York |
0 |
0.04 |
| Nose |
0 |
0.04 |
| Pain |
0 |
0.04 |
| Respiratory Tract |
0 |
0.04 |
| Steroids |
0 |
0.04 |
| Stomach |
0 |
0.04 |
| Thrombosis |
0 |
0.04 |
| Tumor |
0 |
0.04 |
| Weight Gain |
0 |
0.04 |
| Antibiotics |
0 |
0.03 |
| Candidiasis |
0 |
0.03 |
| COVID-19 |
0 |
0.03 |
| Headache |
0 |
0.03 |
| Hepatitis B Virus |
0 |
0.03 |
| Lipids Management |
0 |
0.03 |
| Neutropenia |
0 |
0.03 |
| Revenue and Practice Management |
0 |
0.03 |
| Tuberculosis |
0 |
0.03 |
| Urinary Tract Infection |
0 |
0.03 |
| Weight Management |
0 |
0.03 |